Transcription profiling of human prostate carcinoma cell line PC3 treated with reverse transcriptase inhibitor abacavir
ID:
状态:
发布时间Aug. 15, 2009
, 更新时间 May 2, 2014
, 提交时间 Aug. 14, 2008,
物种:
Homo sapiens
摘要:
Human prostate carcinoma cell line PC3 was treated with 10mg/ml or 100mg/ml of Abacavir. Gene expression was analyzed on total RNA extracted 48h after treatement. For each condition, 5 indipendent biological replicates were performed